Tumors of infectious origin globally represent 13%. Oncogenic DNA viruses such as human papillomavirus (HPV), hepatitis B virus (HBV), and Epstein-Barr virus (EBV) are responsible for approximately 60% of these tumors. These oncoviruses are extensively studied to understand their role in cancer development, particularly through viral genome integration into the host DNA. Retroviruses require integration mediated by viral integrase for persistence, whereas DNA oncoviruses do not need integration for replication; instead, integration occurs incidentally. This process often targets fragile sites in the human genome, causing structural rearrangements that disrupt genes, activate proto-oncogenes, and increase genomic instability, all contributing to tumorigenesis. Integration near promoter regions and active genes is closely linked to carcinogenesis, highlighting its importance in developing diagnostic and therapeutic strategies. This review summarizes viral integration's role in oncogenesis, mechanisms of integration, and methods to study this process, focusing on DNA tumor viruses such as HBV, EBV, HPV, and Merkel cell polyomavirus.

Department of Genetics and Microbiology Faculty of Science BIOCEV Charles University Prague Czech Republic

Zobrazit více v PubMed

de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. 2020. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health 8:e180–e190. doi: 10.1016/S2214-109X(19)30488-7 PubMed DOI

Grandgenett DP, Mumm SR. 1990. Unraveling retrovirus integration. Cell 60:3–4. doi: 10.1016/0092-8674(90)90707-l PubMed DOI

Serrao E, Engelman AN. 2016. Sites of retroviral DNA integration: from basic research to clinical applications. Crit Rev Biochem Mol Biol 51:26–42. doi: 10.3109/10409238.2015.1102859 PubMed DOI PMC

Lesbats P, Engelman AN, Cherepanov P. 2016. Retroviral DNA integration. Chem Rev 116:12730–12757. doi: 10.1021/acs.chemrev.6b00125 PubMed DOI PMC

Maertens GN, Engelman AN, Cherepanov P. 2022. Structure and function of retroviral integrase. Nat Rev Microbiol 20:20–34. doi: 10.1038/s41579-021-00586-9 PubMed DOI PMC

Gravel A, Dubuc I, Morissette G, Sedlak RH, Jerome KR, Flamand L. 2015. Inherited chromosomally integrated human herpesvirus 6 as a predisposing risk factor for the development of angina pectoris. Proc Natl Acad Sci USA 112:8058–8063. doi: 10.1073/pnas.1502741112 PubMed DOI PMC

Hill JA, Magaret AS, Hall-Sedlak R, Mikhaylova A, Huang M-L, Sandmaier BM, Hansen JA, Jerome KR, Zerr DM, Boeckh M. 2017. Outcomes of hematopoietic cell transplantation using donors or recipients with inherited chromosomally integrated HHV-6. Blood 130:1062–1069. doi: 10.1182/blood-2017-03-775759 PubMed DOI PMC

Gravel A, Dubuc I, Brooks-Wilson A, Aronson KJ, Simard J, Velásquez-García HA, Spinelli JJ, Flamand L. 2017. Inherited chromosomally integrated human herpesvirus 6 and breast cancer. Cancer Epidemiol Biomarkers Prev 26:425–427. doi: 10.1158/1055-9965.EPI-16-0735 PubMed DOI

Global hepatitis report. 2024. Available from: https://www.who.int/publications/b/68511. Retrieved 15 Jul 2025.

Pollicino T, Caminiti G. 2021. HBV-integration studies in the clinic: role in the natural history of infection. Viruses 13:368. doi: 10.3390/v13030368 PubMed DOI PMC

Shi Y-H, Shi C-H. 2009. Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15:3099–3105. doi: 10.3748/wjg.15.3099 PubMed DOI PMC

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. doi: 10.3322/caac.21660 PubMed DOI

Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. 2016. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 4:e609–e616. doi: 10.1016/S2214-109X(16)30143-7 PubMed DOI

Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 3:e00049. doi: 10.7554/eLife.00049 PubMed DOI PMC

Long Q, Yan R, Hu J, Cai D, Mitra B, Kim ES, Marchetti A, Zhang H, Wang S, Liu Y, Huang A, Guo H. 2017. The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation. PLoS Pathog 13:e1006784. doi: 10.1371/journal.ppat.1006784 PubMed DOI PMC

Kitamura K, Que L, Shimadu M, Koura M, Ishihara Y, Wakae K, Nakamura T, Watashi K, Wakita T, Muramatsu M. 2018. Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus. PLoS Pathog 14:e1007124. doi: 10.1371/journal.ppat.1007124 PubMed DOI PMC

Tang L, Sheraz M, McGrane M, Chang J, Guo J-T. 2019. DNA polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA. PLoS Pathog 15:e1007742. doi: 10.1371/journal.ppat.1007742 PubMed DOI PMC

Haines KM, Loeb DD. 2007. The sequence of the RNA primer and the DNA template influence the initiation of plus-strand DNA synthesis in hepatitis B virus. J Mol Biol 370:471–480. doi: 10.1016/j.jmb.2007.04.057 PubMed DOI PMC

Zhao X-L, Yang J-R, Lin S-Z, Ma H, Guo F, Yang R-F, Zhang H-H, Han J-C, Wei L, Pan X-B. 2016. Serum viral duplex-linear DNA proportion increases with the progression of liver disease in patients infected with HBV. Gut 65:502–511. doi: 10.1136/gutjnl-2014-308989 PubMed DOI

Tu T, Budzinska MA, Vondran FWR, Shackel NA, Urban S. 2018. Hepatitis B virus DNA integration occurs early in the viral life cycle in an in vitro infection model via sodium taurocholate cotransporting polypeptide-dependent uptake of enveloped virus particles. J Virol 92:e02007-17. doi: 10.1128/JVI.02007-17 PubMed DOI PMC

Brechot C, Pourcel C, Louise A, Rain B, Tiollais P. 1980. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286:533–535. doi: 10.1038/286533a0 PubMed DOI

Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC. 1981. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med 305:1067–1073. doi: 10.1056/NEJM198110293051807 PubMed DOI

Kimbi GC, Kramvis A, Kew MC. 2005. Integration of hepatitis B virus DNA into chromosomal DNA during acute hepatitis B. World J Gastroenterol 11:6416–6421. doi: 10.3748/wjg.v11.i41.6416 PubMed DOI PMC

Bréchot C. 2004. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127:S56–S61. doi: 10.1053/j.gastro.2004.09.016 PubMed DOI

Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Bréchot C, Paterlini-Bréchot P. 2005. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 54:1162–1168. doi: 10.1136/gut.2004.054452 PubMed DOI PMC

Péneau C, Imbeaud S, La Bella T, Hirsch TZ, Caruso S, Calderaro J, Paradis V, Blanc J-F, Letouzé E, Nault J-C, Amaddeo G, Zucman-Rossi J. 2022. Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma. Gut 71:616–626. doi: 10.1136/gutjnl-2020-323153 PubMed DOI PMC

Zhao L-H, Liu X, Yan H-X, Li W-Y, Zeng X, Yang Y, Zhao J, Liu S-P, Zhuang X-H, Lin C, et al. 2016. Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun 7:12992. doi: 10.1038/ncomms12992 PubMed DOI PMC

Berasain C, Castillo J, Perugorria MJ, Latasa MU, Prieto J, Avila MA. 2009. Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci 1155:206–221. doi: 10.1111/j.1749-6632.2009.03704.x PubMed DOI

Chen Y, Tian Z. 2019. HBV-induced immune imbalance in the development of HCC. Front Immunol 10:2048. doi: 10.3389/fimmu.2019.02048 PubMed DOI PMC

Zhang HH, Mei MH, Fei R, Liu F, Wang JH, Liao WJ, Qin LL, Wei L, Chen HS. 2010. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses. J Viral Hepat 17:34–43. doi: 10.1111/j.1365-2893.2010.01269.x PubMed DOI

Kim CM, Koike K, Saito I, Miyamura T, Jay G. 1991. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317–320. doi: 10.1038/351317a0 PubMed DOI

Sivasudhan E, Blake N, Lu Z, Meng J, Rong R. 2022. Hepatitis B viral protein HBx and the molecular mechanisms modulating the hallmarks of hepatocellular carcinoma: a comprehensive review. Cells 11:741. doi: 10.3390/cells11040741 PubMed DOI PMC

Horikawa I, Barrett JC. 2001. cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome. J Natl Cancer Inst 93:1171–1173. doi: 10.1093/jnci/93.15.1171 PubMed DOI

Lin SY, Zhang A, Lian J, Wang J, Chang T-T, Lin Y-J, Song W, Su Y-H. 2021. Recurrent HBV integration targets as potential drivers in hepatocellular carcinoma. Cells 10:1294. doi: 10.3390/cells10061294 PubMed DOI PMC

Feitelson MA, Lee J. 2007. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett 252:157–170. doi: 10.1016/j.canlet.2006.11.010 PubMed DOI

Sung W-K, Zheng H, Li S, Chen R, Liu X, Li Y, Lee NP, Lee WH, Ariyaratne PN, Tennakoon C, et al. 2012. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 44:765–769. doi: 10.1038/ng.2295 PubMed DOI

Jang J-W, Kim H-S, Kim J-S, Lee S-K, Han J-W, Sung P-S, Bae S-H, Choi J-Y, Yoon S-K, Han D-J, Kim T-M, Roberts LR. 2021. Distinct patterns of HBV integration and TERT alterations between in tumor and non-tumor tissue in patients with hepatocellular carcinoma. Int J Mol Sci 22:7056. doi: 10.3390/ijms22137056 PubMed DOI PMC

Schlüter V, Meyer M, Hofschneider PH, Koshy R, Caselmann WH. 1994. Integrated hepatitis B virus X and 3’ truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. Oncogene 9:3335–3344. PubMed

Liu X-H, Lin J, Zhang S-H, Zhang S-M, Feitelson M-A, Gao H-J, Zhu M-H. 2008. COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma. World J Gastroenterol 14:1346. doi: 10.3748/wjg.14.1346 PubMed DOI PMC

Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, Aoki M, Hosono N, Kubo M, Miya F, et al. 2012. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 44:760–764. doi: 10.1038/ng.2291 PubMed DOI

Jiang S, Yang Z, Li W, Li X, Wang Y, Zhang J, Xu C, Chen P-J, Hou J, McCrae MA, Chen X, Zhuang H, Lu F. 2012. Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis. PLoS One 7:e40363. doi: 10.1371/journal.pone.0040363 PubMed DOI PMC

Yang X, Wu L, Lin J, Wang A, Wan X, Wu Y, Robson SC, Sang X, Zhao H. 2017. Distinct hepatitis B virus integration patterns in hepatocellular carcinoma and adjacent normal liver tissue. Int J Cancer 140:1324–1330. doi: 10.1002/ijc.30547 PubMed DOI

Katoh H, Shibata T, Kokubu A, Ojima H, Loukopoulos P, Kanai Y, Kosuge T, Fukayama M, Kondo T, Sakamoto M, Hosoda F, Ohki M, Imoto I, Inazawa J, Hirohashi S. 2005. Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome. J Hepatol 43:863–874. doi: 10.1016/j.jhep.2005.05.033 PubMed DOI

Li C-L, Ho M-C, Lin Y-Y, Tzeng S-T, Chen Y-J, Pai H-Y, Wang Y-C, Chen C-L, Lee Y-H, Chen D-S, Yeh S-H, Chen P-J. 2020. Cell-free virus-host chimera DNA from hepatitis B virus integration sites as a circulating biomarker of hepatocellular cancer. Hepatology 72:2063–2076. doi: 10.1002/hep.31230 PubMed DOI

Salpini R, D’Anna S, Benedetti L, Piermatteo L, Gill U, Svicher V, Kennedy PTF. 2022. Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure. Front Microbiol 13:972687. doi: 10.3389/fmicb.2022.972687 PubMed DOI PMC

Epstein MA, Achong BG, Barr YM. 1964. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1:702–703. doi: 10.1016/s0140-6736(64)91524-7 PubMed DOI

Rostgaard K, Balfour HH, Jarrett R, Erikstrup C, Pedersen O, Ullum H, Nielsen LP, Voldstedlund M, Hjalgrim H. 2019. Primary Epstein-Barr virus infection with and without infectious mononucleosis. PLoS One 14:e0226436. doi: 10.1371/journal.pone.0226436 PubMed DOI PMC

Su ZY, Siak PY, Leong C-O, Cheah S-C. 2023. The role of Epstein-Barr virus in nasopharyngeal carcinoma. Front Microbiol 14:1116143. doi: 10.3389/fmicb.2023.1116143 PubMed DOI PMC

Campanero MR. 2008. Mechanisms involved in Burkitt’s tumor formation. Clin Transl Oncol 10:250–255. doi: 10.1007/s12094-008-0193-x PubMed DOI

Allen PB, Lechowicz MJ. 2019. Management of NK/T-cell lymphoma, nasal type. J Oncol Pract 15:513–520. doi: 10.1200/JOP.18.00719 PubMed DOI PMC

Farrell K, Jarrett RF. 2011. The molecular pathogenesis of Hodgkin lymphoma. Histopathology 58:15–25. doi: 10.1111/j.1365-2559.2010.03705.x PubMed DOI

Sun K, Jia K, Lv H, Wang S-Q, Wu Y, Lei H, Chen X. 2020. EBV-positive gastric cancer: current knowledge and future perspectives. Front Oncol 10:583463. doi: 10.3389/fonc.2020.583463 PubMed DOI PMC

Khan G, Fitzmaurice C, Naghavi M, Ahmed LA. 2020. Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990-2017. BMJ Open 10:e037505. doi: 10.1136/bmjopen-2020-037505 PubMed DOI PMC

Chakravorty S, Yan B, Wang C, Wang L, Quaid JT, Lin CF, Briggs SD, Majumder J, Canaria DA, Chauss D, Chopra G, Olson MR, Zhao B, Afzali B, Kazemian M. 2019. Integrated pan-cancer map of EBV-associated neoplasms reveals functional host-virus interactions. Cancer Res 79:6010–6023. doi: 10.1158/0008-5472.CAN-19-0615 PubMed DOI PMC

Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. 2022. Estimating the global burden of Epstein–Barr virus-related cancers. J Cancer Res Clin Oncol 148:31–46. doi: 10.1007/s00432-021-03824-y PubMed DOI PMC

Al-Anazi AE, Alanazi BS, Alshanbari HM, Masuadi E, Hamed ME, Dandachi I, Alkathiri A, Hanif A, Nour I, Fatani H, Alsaran H, AlKhareeb F, Al Zahrani A, Alsharm AA, Eifan S, Alosaimi B. 2023. Increased prevalence of EBV infection in nasopharyngeal carcinoma patients: a six-year cross-sectional study. Cancers (Basel) 15:643. doi: 10.3390/cancers15030643 PubMed DOI PMC

Donzel M, Bonjour M, Combes J-D, Broussais F, Sesques P, Traverse-Glehen A, de Martel C. 2022. Lymphomas associated with Epstein-Barr virus infection in 2020: results from a large, unselected case series in France. EClinicalMedicine 54:101674. doi: 10.1016/j.eclinm.2022.101674 PubMed DOI PMC

Farisyi MA, Sufiawati I. 2020. Detection of Epstein–Barr virus DNA in saliva of HIV-1-infected individuals with oral hairy leukoplakia. Oral Dis 26:158–160. doi: 10.1111/odi.13400 PubMed DOI

Soldan SS, Lieberman PM. 2023. Epstein–Barr virus and multiple sclerosis. Nat Rev Microbiol 21:51–64. doi: 10.1038/s41579-022-00770-5 PubMed DOI PMC

Tarbouriech N, Buisson M, Géoui T, Daenke S, Cusack S, Burmeister WP. 2006. Structural genomics of the Epstein–Barr virus. Acta Crystallogr D Biol Crystallogr 62:1276–1285. doi: 10.1107/S0907444906030034 PubMed DOI

Moss WN, Lee N, Pimienta G, Steitz JA. 2014. RNA families in Epstein-Barr virus. RNA Biol 11:10–17. doi: 10.4161/rna.27488 PubMed DOI PMC

Skalsky RL, Cullen BR. 2015. EBV noncoding RNAs. Curr Top Microbiol Immunol 391:181–217. doi: 10.1007/978-3-319-22834-1_6 PubMed DOI PMC

Farrell PJ. 2019. Epstein-Barr virus and cancer. Annu Rev Pathol 14:29–53. doi: 10.1146/annurev-pathmechdis-012418-013023 PubMed DOI

Chesnokova LS, Jiang R, Hutt-Fletcher LM. 2015. Viral entry. Curr Top Microbiol Immunol 391:221–235. doi: 10.1007/978-3-319-22834-1_7 PubMed DOI

Jean-Pierre V, Lupo J, Buisson M, Morand P, Germi R. 2021. Main targets of interest for the development of a prophylactic or therapeutic Epstein-Barr virus vaccine. Front Microbiol 12:701611. doi: 10.3389/fmicb.2021.701611 PubMed DOI PMC

Miller N, Hutt-Fletcher LM. 1992. Epstein-Barr virus enters B cells and epithelial cells by different routes. J Virol 66:3409–3414. doi: 10.1128/JVI.66.6.3409-3414.1992 PubMed DOI PMC

Valencia SM, Hutt-Fletcher LM. 2012. Important but differential roles for actin in trafficking of Epstein-Barr virus in B cells and epithelial cells. J Virol 86:2–10. doi: 10.1128/JVI.05883-11 PubMed DOI PMC

Lee C-P, Chen M-R. 2021. Conquering the nuclear envelope barriers by EBV lytic replication. Viruses 13:702. doi: 10.3390/v13040702 PubMed DOI PMC

Murata T. 2014. Regulation of Epstein–Barr virus reactivation from latency. Microbiol Immunol 58:307–317. doi: 10.1111/1348-0421.12155 PubMed DOI

Hammerschmidt W. 2015. The epigenetic life cycle of Epstein-Barr virus. Curr Top Microbiol Immunol 390:103–117. doi: 10.1007/978-3-319-22822-8_6 PubMed DOI

Sausen DG, Bhutta MS, Gallo ES, Dahari H, Borenstein R. 2021. Stress-induced Epstein-Barr virus reactivation. Biomolecules 11:1380. doi: 10.3390/biom11091380 PubMed DOI PMC

Gruhne B, Sompallae R, Masucci MG. 2009. Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene 28:3997–4008. doi: 10.1038/onc.2009.258 PubMed DOI

Deng W, Pang PS, Tsang CM, Hau PM, Yip YL, Cheung ALM, Tsao SW. 2012. Epstein-Barr virus-encoded latent membrane protein 1 impairs G2 checkpoint in human nasopharyngeal epithelial cells through defective Chk1 activation. PLoS One 7:e39095. doi: 10.1371/journal.pone.0039095 PubMed DOI PMC

Dolcetti R, Dal Col J, Martorelli D, Carbone A, Klein E. 2013. Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas. Semin Cancer Biol 23:441–456. doi: 10.1016/j.semcancer.2013.07.005 PubMed DOI

Tsao S-W, Tsang CM, To K-F, Lo K-W. 2015. The role of Epstein–Barr virus in epithelial malignancies. J Pathol 235:323–333. doi: 10.1002/path.4448 PubMed DOI PMC

Tsang CM, Lui VWY, Bruce JP, Pugh TJ, Lo KW. 2020. Translational genomics of nasopharyngeal cancer. Semin Cancer Biol 61:84–100. doi: 10.1016/j.semcancer.2019.09.006 PubMed DOI

Shumilov A, Tsai M-H, Schlosser YT, Kratz A-S, Bernhardt K, Fink S, Mizani T, Lin X, Jauch A, Mautner J, Kopp-Schneider A, Feederle R, Hoffmann I, Delecluse H-J. 2017. Epstein-Barr virus particles induce centrosome amplification and chromosomal instability. Nat Commun 8:14257. doi: 10.1038/ncomms14257 PubMed DOI PMC

Hurley EA, Agger S, McNeil JA, Lawrence JB, Calendar A, Lenoir G, Thorley-Lawson DA. 1991. When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates. J Virol 65:1245–1254. doi: 10.1128/JVI.65.3.1245-1254.1991 PubMed DOI PMC

Ohshima K, Suzumiya J, Kanda M, Kato A, Kikuchi M. 1998. Integrated and episomal forms of Epstein–Barr virus (EBV) in EBV associated disease. Cancer Lett 122:43–50. doi: 10.1016/S0304-3835(97)00368-6 PubMed DOI

Xiao K, Yu Z, Li X, Li X, Tang K, Tu C, Qi P, Liao Q, Chen P, Zeng Z, Li G, Xiong W. 2016. Genome-wide analysis of Epstein-Barr Virus (EBV) integration and strain in C666-1 and Raji cells. J Cancer 7:214–224. doi: 10.7150/jca.13150 PubMed DOI PMC

Peng R-J, Han B-W, Cai Q-Q, Zuo X-Y, Xia T, Chen J-R, Feng L-N, Lim JQ, Chen S-W, Zeng M-S, Guo Y-M, Li B, Xia X-J, Xia Y, Laurensia Y, Chia BKH, Huang H-Q, Young KH, Lim ST, Ong CK, Zeng Y-X, Bei J-X. 2019. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma. Leukemia 33:1451–1462. doi: 10.1038/s41375-018-0324-5 PubMed DOI PMC

Koliais SI. 1979. Mode of integration of Epstein-Barr virus genome into host DNA in Burkitt lymphoma cells. J Gen Virol 44:573–576. doi: 10.1099/0022-1317-44-2-573 PubMed DOI

Anvret M, Karlsson A, Bjursell G. 1984. Evidence for integrated EBV genomes in Raji cellular DNA. Nucleic Acids Res 12:1149–1161. doi: 10.1093/nar/12.2.1149 PubMed DOI PMC

Kieff E, Hennessy K, Fennewald S, Matsuo T, Dambaugh T, Heller M, Hummel M. 1985. Biochemistry of latent Epstein-Barr virus infection and associated cell growth transformation, p 323–339. IARC scientific publications. PubMed

Xu M, Zhang W-L, Zhu Q, Zhang S, Yao Y-Y, Xiang T, Feng Q-S, Zhang Z, Peng R-J, Jia W-H, He G-P, Feng L, Zeng Z-L, Luo B, Xu R-H, Zeng M-S, Zhao W-L, Chen S-J, Zeng Y-X, Jiao Y. 2019. Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies. Theranostics 9:1115–1124. doi: 10.7150/thno.29622 PubMed DOI PMC

Delecluse HJ, Bartnizke S, Hammerschmidt W, Bullerdiek J, Bornkamm GW. 1993. Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines. J Virol 67:1292–1299. doi: 10.1128/JVI.67.3.1292-1299.1993 PubMed DOI PMC

Kripalani-Joshi S, Law HY. 1994. Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis. Int J Cancer 56:187–192. doi: 10.1002/ijc.2910560207 PubMed DOI

Takakuwa T, Luo W-J, Ham MF, Sakane-Ishikawa F, Wada N, Aozasa K. 2004. Integration of Epstein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of BACH2 expression. Am J Pathol 164:967–974. doi: 10.1016/S0002-9440(10)63184-7 PubMed DOI PMC

Zhang L, Wang R, Xie Z. 2022. The roles of DNA methylation on the promotor of the Epstein–Barr virus (EBV) gene and the genome in patients with EBV-associated diseases. Appl Microbiol Biotechnol 106:4413–4426. doi: 10.1007/s00253-022-12029-3 PubMed DOI PMC

Luo W-J, Takakuwa T, Ham MF, Wada N, Liu A, Fujita S, Sakane-Ishikawa E, Aozasa K. 2004. Epstein-Barr virus is integrated between REL and BCL-11A in American Burkitt lymphoma cell line (NAB-2). Lab Invest 84:1193–1199. doi: 10.1038/labinvest.3700152 PubMed DOI

Janjetovic S, Hinke J, Balachandran S, Akyüz N, Behrmann P, Bokemeyer C, Dierlamm J, Murga Penas EM. 2022. Non-random pattern of integration for epstein-barr virus with preference for gene-poor genomic chromosomal regions into the genome of burkitt lymphoma cell lines. Viruses 14:86. doi: 10.3390/v14010086 PubMed DOI PMC

Tang D, Li B, Xu T, Hu R, Tan D, Song X, Jia P, Zhao Z. 2020. VISDB: a manually curated database of viral integration sites in the human genome. Nucleic Acids Res 48:D633–D641. doi: 10.1093/nar/gkz867 PubMed DOI PMC

Gao J, Luo X, Tang K, Li X, Li G. 2006. Epstein-Barr virus integrates frequently into chromosome 4q, 2q, 1q and 7q of Burkitt’s lymphoma cell line (Raji). J Virol Methods 136:193–199. doi: 10.1016/j.jviromet.2006.05.013 PubMed DOI

Gasenko E, Isajevs S, Camargo MC, Offerhaus GJA, Polaka I, Gulley ML, Skapars R, Sivins A, Kojalo I, Kirsners A, Santare D, Pavlova J, Sjomina O, Liepina E, Tzivian L, Rabkin CS, Leja M. 2019. Clinicopathological characteristics of Epstein-Barr virus-positive gastric cancer in Latvia. Eur J Gastroenterol Hepatol 31:1328–1333. doi: 10.1097/MEG.0000000000001521 PubMed DOI PMC

He C-Y, Qiu M-Z, Yang X-H, Zhou D-L, Ma J-J, Long Y-K, Ye Z-L, Xu B-H, Zhao Q, Jin Y, Lu S-X, Wang Z-Q, Guan W-L, Zhao B-W, Zhou Z-W, Shao J-Y, Xu R-H. 2020. Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosis. Clin Transl Med 10:353–362. doi: 10.1002/ctm2.32 PubMed DOI PMC

Qiu M-Z, He C-Y, Lu S-X, Guan W-L, Wang F, Wang X-J, Jin Y, Wang F-H, Li Y-H, Shao J-Y, Zhou Z-W, Yun J-P, Xu R-H. 2020. Prospective observation: clinical utility of plasma Epstein-Barr virus DNA load in EBV-associated gastric carcinoma patients. Int J Cancer 146:272–280. doi: 10.1002/ijc.32490 PubMed DOI

PaVE . 2025. Available from: https://pave.niaid.nih.gov. Retrieved 06 Mar 2025.

Burchell AN, Winer RL, de Sanjosé S, Franco EL. 2006. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine (Auckl) 24:S3 doi: 10.1016/j.vaccine.2006.05.031 PubMed DOI

Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. 2010. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202:1789–1799. doi: 10.1086/657321 PubMed DOI

Human papillomavirus and cancer. 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer. Retrieved Jul 2025.

Bruni L, Albero G, Rowley J, Alemany L, Arbyn M, Giuliano AR, Markowitz LE, Broutet N, Taylor M. 2023. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet Glob Health 11:e1345–e1362. doi: 10.1016/S2214-109X(23)00305-4 PubMed DOI PMC

Malik H, Khan FH, Ahsan H. 2014. Human papillomavirus: current status and issues of vaccination. Arch Virol 159:199–205. doi: 10.1007/s00705-013-1827-z PubMed DOI

Serrano B, Albero G, Bruni L2025. Fact Sheet World 262. Available from: https://www.hpvworld.com/articles/fact-sheet-world. Retrieved 6 Jun 2025.

de Martel C, Plummer M, Vignat J, Franceschi S. 2017. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 141:664–670. doi: 10.1002/ijc.30716 PubMed DOI PMC

Ndon S, Singh A, Ha PK, Aswani J, Chan J-K, Xu MJ. 2023. Human papillomavirus-associated oropharyngeal cancer: global epidemiology and public policy implications. Cancers (Basel) 15:4080. doi: 10.3390/cancers15164080 PubMed DOI PMC

de Sanjosé S, Brotons M, Pavón MA. 2018. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol 47:2–13. doi: 10.1016/j.bpobgyn.2017.08.015 PubMed DOI

Mikuličić S, Strunk J, Florin L. 2021. HPV16 entry into epithelial cells: running a gauntlet. Viruses 13:2460. doi: 10.3390/v13122460 PubMed DOI PMC

McBride AA. 2008. Replication and partitioning of papillomavirus genomes. Adv Virus Res 72:155–205. doi: 10.1016/S0065-3527(08)00404-1 PubMed DOI PMC

Radley D, Saah A, Stanley M. 2016. Persistent infection with human papillomavirus 16 or 18 is strongly linked with high-grade cervical disease. Hum Vaccin Immunother 12:768–772. doi: 10.1080/21645515.2015.1088616 PubMed DOI PMC

Moscicki A-B, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, Miller S, Canjura-Clayton KL, Farhat S, Broering JM, Darragh TM. 2004. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 364:1678–1683. doi: 10.1016/S0140-6736(04)17354-6 PubMed DOI

Ostör AG. 1993. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12:186–192. PubMed

Basu P, Taghavi K, Hu S-Y, Mogri S, Joshi S. 2018. Management of cervical premalignant lesions. Curr Probl Cancer 42:129–136. doi: 10.1016/j.currproblcancer.2018.01.010 PubMed DOI

Bhattacharjee R, Das SS, Biswal SS, Nath A, Das D, Basu A, Malik S, Kumar L, Kar S, Singh SK, Upadhye VJ, Iqbal D, Almojam S, Roychoudhury S, Ojha S, Ruokolainen J, Jha NK, Kesari KK. 2022. Mechanistic role of HPV-associated early proteins in cervical cancer: molecular pathways and targeted therapeutic strategies. Crit Rev Oncol Hematol 174:103675. doi: 10.1016/j.critrevonc.2022.103675 PubMed DOI

Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495–505. doi: 10.1016/0092-8674(93)90384-3 PubMed DOI

Beaudenon S, Huibregtse JM. 2008. HPV E6, E6AP and cervical cancer. BMC Biochem 9:S4. doi: 10.1186/1471-2091-9-S1-S4 PubMed DOI PMC

Mortensen F, Schneider D, Barbic T, Sladewska-Marquardt A, Kühnle S, Marx A, Scheffner M. 2015. Role of ubiquitin and the HPV E6 oncoprotein in E6AP-mediated ubiquitination. Proc Natl Acad Sci USA 112:9872–9877. doi: 10.1073/pnas.1505923112 PubMed DOI PMC

Zimmermann H, Degenkolbe R, Bernard HU, O’Connor MJ. 1999. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol 73:6209–6219. doi: 10.1128/JVI.73.8.6209-6219.1999 PubMed DOI PMC

Patel D, Huang SM, Baglia LA, McCance DJ. 1999. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J 18:5061–5072. doi: 10.1093/emboj/18.18.5061 PubMed DOI PMC

Yoshimatsu Y, Nakahara T, Tanaka K, Inagawa Y, Narisawa-Saito M, Yugawa T, Ohno S-I, Fujita M, Nakagama H, Kiyono T. 2017. Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytes. Cancer Sci 108:1303–1309. doi: 10.1111/cas.13264 PubMed DOI PMC

Ronco LV, Karpova AY, Vidal M, Howley PM. 1998. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12:2061–2072. doi: 10.1101/gad.12.13.2061 PubMed DOI PMC

Liu X, Dakic A, Zhang Y, Dai Y, Chen R, Schlegel R. 2009. HPV E6 protein interacts physically and functionally with the cellular telomerase complex. Proc Natl Acad Sci USA 106:18780–18785. doi: 10.1073/pnas.0906357106 PubMed DOI PMC

Münger K, Howley PM. 2002. Human papillomavirus immortalization and transformation functions. Virus Res 89:213–228. doi: 10.1016/s0168-1702(02)00190-9 PubMed DOI

Longworth MS, Laimins LA. 2004. The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J Virol 78:3533–3541. doi: 10.1128/JVI.78.7.3533-3541.2004 PubMed DOI PMC

McLaughlin-Drubin ME, Münger K. 2009. The human papillomavirus E7 oncoprotein. Virology (Auckl) 384:335–344. doi: 10.1016/j.virol.2008.10.006 PubMed DOI PMC

Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE, Um SJ. 2000. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem 275:6764–6769. doi: 10.1074/jbc.275.10.6764 PubMed DOI

Um S-J, Rhyu J-W, Kim E-J, Jeon K-C, Hwang E-S, Park J-S. 2002. Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo. Cancer Lett 179:205–212. doi: 10.1016/s0304-3835(01)00871-0 PubMed DOI

Tomakidi P, Cheng H, Kohl A, Komposch G, Alonso A. 2000. Modulation of the epidermal growth factor receptor by the human papillomavirus type 16 E5 protein in raft cultures of human keratinocytes. Eur J Cell Biol 79:407–412. doi: 10.1078/0171-9335-00060 PubMed DOI

Wasson CW, Morgan EL, Müller M, Ross RL, Hartley M, Roberts S, Macdonald A. 2017. Human papillomavirus type 18 E5 oncogene supports cell cycle progression and impairs epithelial differentiation by modulating growth factor receptor signalling during the virus life cycle. Oncotarget 8:103581–103600. doi: 10.18632/oncotarget.21658 PubMed DOI PMC

Oh J-M, Kim S-H, Cho E-A, Song Y-S, Kim W-H, Juhnn Y-S. 2010. Human papillomavirus type 16 E5 protein inhibits hydrogen peroxide-induced apoptosis by stimulating ubiquitin–proteasome-mediated degradation of Bax in human cervical cancer cells. Carcinogenesis 31:402–410. doi: 10.1093/carcin/bgp318 PubMed DOI

Kim S-H, Juhnn Y-S, Kang S, Park S-W, Sung M-W, Bang Y-J, Song Y-S. 2006. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt. Cell Mol Life Sci 63:930–938. doi: 10.1007/s00018-005-5561-x PubMed DOI PMC

Ilahi NE, Bhatti A. 2020. Impact of HPV E5 on viral life cycle via EGFR signaling. Microb Pathog 139:103923. doi: 10.1016/j.micpath.2019.103923 PubMed DOI

Kim S-H, Oh J-M, No J-H, Bang Y-J, Juhnn Y-S, Song Y-S. 2009. Involvement of NF-κB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein. Carcinogenesis 30:753–757. doi: 10.1093/carcin/bgp066 PubMed DOI

Hatano T, Sano D, Takahashi H, Oridate N. 2021. Pathogenic role of immune evasion and integration of human papillomavirus in oropharyngeal cancer. Microorganisms 9:891. doi: 10.3390/microorganisms9050891 PubMed DOI PMC

Moody CA, Laimins LA. 2009. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog 5:e1000605. doi: 10.1371/journal.ppat.1000605 PubMed DOI PMC

Hong S, Laimins LA. 2013. Regulation of the life cycle of HPVs by differentiation and the DNA damage response. Future Microbiol 8:1547–1557. doi: 10.2217/fmb.13.127 PubMed DOI PMC

Spriggs CC, Laimins LA. 2017. FANCD2 binds human papillomavirus genomes and associates with a distinct set of DNA repair proteins to regulate viral replication. mBio 8:e02340-16. doi: 10.1128/mBio.02340-16 PubMed DOI PMC

Kono T, Laimins L. 2021. Genomic instability and DNA damage repair pathways induced by human papillomaviruses. Viruses 13:1821. doi: 10.3390/v13091821 PubMed DOI PMC

Williams VM, Filippova M, Filippov V, Payne KJ, Duerksen-Hughes P. 2014. Human papillomavirus type 16 E6* induces oxidative stress and DNA damage. J Virol 88:6751–6761. doi: 10.1128/JVI.03355-13 PubMed DOI PMC

Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP, Munger K. 2000. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 97:10002–10007. doi: 10.1073/pnas.170093297 PubMed DOI PMC

Duensing S, Duensing A, Crum CP, Münger K. 2001. Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. Cancer Res 61:2356–2360. PubMed

Korzeniewski N, Spardy N, Duensing A, Duensing S. 2011. Genomic instability and cancer: lessons learned from human papillomaviruses. Cancer Lett 305:113–122. doi: 10.1016/j.canlet.2010.10.013 PubMed DOI PMC

Hudelist G, Manavi M, Pischinger KID, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF. 2004. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol 92:873–880. doi: 10.1016/j.ygyno.2003.11.035 PubMed DOI

Briolat J, Dalstein V, Saunier M, Joseph K, Caudroy S, Prétet J-L, Birembaut P, Clavel C. 2007. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Cancer 121:2198–2204. doi: 10.1002/ijc.22959 PubMed DOI

Khoury JD, Tannir NM, Williams MD, Chen Y, Yao H, Zhang J, Thompson EJ, TCGA Network, Meric-Bernstam F, Medeiros LJ, Weinstein JN, Su X. 2013. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol 87:8916–8926. doi: 10.1128/JVI.00340-13 PubMed DOI PMC

Vojtechova Z, Sabol I, Salakova M, Turek L, Grega M, Smahelova J, Vencalek O, Lukesova E, Klozar J, Tachezy R. 2016. Analysis of the integration of human papillomaviruses in head and neck tumours in relation to patients’ prognosis. Int J Cancer 138:386–395. doi: 10.1002/ijc.29712 PubMed DOI

Cancer Genome Atlas Research Network, Albert Einstein College of Medicine, Analytical Biological Services, Barretos Cancer Hospital, Baylor College of Medicine, Beckman Research Institute of City of Hope, Buck Institute for Research on Aging Canada’s Michael Smith Genome Sciences Centre Harvard Medical School, Helen F. Graham Cancer Center & Research Institute at Christiana Care Health Services, et al. 2017. Integrated genomic and molecular characterization of cervical cancer. Nature 543:378–384. doi: 10.1038/nature21386 PubMed DOI PMC

Tang KD, Baeten K, Kenny L, Frazer IH, Scheper G, Punyadeera C. 2019. Unlocking the potential of saliva-based test to detect HPV-16-driven oropharyngeal cancer. Cancers (Basel) 11:473. doi: 10.3390/cancers11040473 PubMed DOI PMC

Mainguené J, Vacher S, Kamal M, Hamza A, Masliah-Planchon J, Baulande S, Ibadioune S, Borcoman E, Cacheux W, Calugaru V, et al. 2022. Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma. Mol Oncol 16:3001–3016. doi: 10.1002/1878-0261.13219 PubMed DOI PMC

Gray E, Pett MR, Ward D, Winder DM, Stanley MA, Roberts I, Scarpini CG, Coleman N. 2010. In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis. Cancer Res 70:4081–4091. doi: 10.1158/0008-5472.CAN-09-3335 PubMed DOI PMC

Rossi NM, Dai J, Xie Y, Wangsa D, Heselmeyer-Haddad K, Lou H, Boland JF, Yeager M, Orozco R, Freites EA, Mirabello L, Gharzouzi E, Dean M. 2023. Extrachromosomal amplification of human papillomavirus episomes is a mechanism of cervical carcinogenesis. Cancer Res 83:1768–1781. doi: 10.1158/0008-5472.CAN-22-3030 PubMed DOI PMC

Chaiwongkot A, Vinokurova S, Pientong C, Ekalaksananan T, Kongyingyoes B, Kleebkaow P, Chumworathayi B, Patarapadungkit N, Reuschenbach M, von Knebel Doeberitz M. 2013. Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions. Int J Cancer 132:2087–2094. doi: 10.1002/ijc.27906 PubMed DOI

Pokrývková B, Saláková M, Šmahelová J, Vojtěchová Z, Novosadová V, Tachezy R. 2019. Detailed characteristics of tonsillar tumors with extrachromosomal or integrated form of human papillomavirus. Viruses 12:42. doi: 10.3390/v12010042 PubMed DOI PMC

Cheung JLK, Cheung T-H, Yu MY, Chan PKS. 2013. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome. Gynecol Oncol 131:374–379. doi: 10.1016/j.ygyno.2013.08.026 PubMed DOI

Ren S, Gaykalova DA, Guo T, Favorov AV, Fertig EJ, Tamayo P, Callejas-Valera JL, Allevato M, Gilardi M, Santos J, Fukusumi T, Sakai A, Ando M, Sadat S, Liu C, Xu G, Fisch KM, Wang Z, Molinolo AA, Gutkind JS, Ideker T, Koch WM, Califano JA. 2020. HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers. Oncogene 39:6327–6339. doi: 10.1038/s41388-020-01431-8 PubMed DOI PMC

Williams VM, Filippova M, Soto U, Duerksen-Hughes PJ. 2011. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virol 6:45–57. doi: 10.2217/fvl.10.73 PubMed DOI PMC

Visalli G, Riso R, Facciolà A, Mondello P, Caruso C, Picerno I, Di Pietro A, Spataro P, Bertuccio MP. 2016. Higher levels of oxidative DNA damage in cervical cells are correlated with the grade of dysplasia and HPV infection. J Med Virol 88:336–344. doi: 10.1002/jmv.24327 PubMed DOI

Kondo S, Wakae K, Wakisaka N, Nakanishi Y, Ishikawa K, Komori T, Moriyama-Kita M, Endo K, Murono S, Wang Z, Kitamura K, Nishiyama T, Yamaguchi K, Shigenobu S, Muramatsu M, Yoshizaki T. 2017. APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers. Oncogene 36:1687–1697. doi: 10.1038/onc.2016.335 PubMed DOI

Zapatka M, Borozan I, Brewer DS, Iskar M, Grundhoff A, Alawi M, Desai N, Sültmann H, Moch H, Cooper CS, Eils R, Ferretti V, Lichter P, PCAWG Pathogens, PCAWG Consortium . 2020. The landscape of viral associations in human cancers. Nat Genet 52:320–330. doi: 10.1038/s41588-019-0558-9 PubMed DOI PMC

Hu Z, Zhu D, Wang W, Li W, Jia W, Zeng X, Ding W, Yu L, Wang X, Wang L, et al. 2015. Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism. Nat Genet 47:158–163. doi: 10.1038/ng.3178 PubMed DOI

Zhang R, Shen C, Zhao L, Wang J, McCrae M, Chen X, Lu F. 2016. Dysregulation of host cellular genes targeted by human papillomavirus (HPV) integration contributes to HPV-related cervical carcinogenesis. Int J Cancer 138:1163–1174. doi: 10.1002/ijc.29872 PubMed DOI PMC

Kamal M, Lameiras S, Deloger M, Morel A, Vacher S, Lecerf C, Dupain C, Jeannot E, Girard E, Baulande S, Dubot C, Kenter G, Jordanova ES, Berns EMJJ, Bataillon G, Popovic M, Rouzier R, Cacheux W, Le Tourneau C, Nicolas A, Servant N, Scholl SM, Bièche I, RAIDs Consortium . 2021. Human papilloma virus (HPV) integration signature in Cervical cancer: identification of MACROD2 gene as HPV hot spot integration site. Br J Cancer 124:777–785. doi: 10.1038/s41416-020-01153-4 PubMed DOI PMC

Fan J, Fu Y, Peng W, Li X, Shen Y, Guo E, Lu F, Zhou S, Liu S, Yang B, et al. 2023. Multi-omics characterization of silent and productive HPV integration in cervical cancer. Cell Genom 3:100211. doi: 10.1016/j.xgen.2022.100211 PubMed DOI PMC

Zeng X, Wang Y, Liu B, Rao X, Cao C, Peng F, Zhi W, Wu P, Peng T, Wei Y, Chu T, Xu M, Xu Y, Ding W, Li G, Lin S, Wu P. 2023. Multi-omics data reveals novel impacts of human papillomavirus integration on the epigenomic and transcriptomic signatures of cervical tumorigenesis. J Med Virol 95:e28789. doi: 10.1002/jmv.28789 PubMed DOI

Thorland EC, Myers SL, Persing DH, Sarkar G, McGovern RM, Gostout BS, Smith DI. 2000. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res 60:5916–5921. PubMed

Bodelon C, Untereiner ME, Machiela MJ, Vinokurova S, Wentzensen N. 2016. Genomic characterization of viral integration sites in HPV-related cancers. Int J Cancer 139:2001–2011. doi: 10.1002/ijc.30243 PubMed DOI PMC

Gao G, Johnson SH, Vasmatzis G, Pauley CE, Tombers NM, Kasperbauer JL, Smith DI. 2017. Common fragile sites (CFS) and extremely large CFS genes are targets for human papillomavirus integrations and chromosome rearrangements in oropharyngeal squamous cell carcinoma. Genes Chromosomes Cancer 56:59–74. doi: 10.1002/gcc.22415 PubMed DOI

Wentzensen N, Vinokurova S, von Knebel Doeberitz M. 2004. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 64:3878–3884. doi: 10.1158/0008-5472.CAN-04-0009 PubMed DOI

Ragin CCR, Reshmi SC, Gollin SM. 2004. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Intl J Cancer 110:701–709. doi: 10.1002/ijc.20193 PubMed DOI

Akagi K, Li J, Broutian TR, Padilla-Nash H, Xiao W, Jiang B, Rocco JW, Teknos TN, Kumar B, Wangsa D, He D, Ried T, Symer DE, Gillison ML. 2014. Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res 24:185–199. doi: 10.1101/gr.164806.113 PubMed DOI PMC

Zhao J, Zheng W, Wang L, Jiang H, Wang X, Hou J, Xu A, Cong J. 2023. Human papillomavirus (HPV) integration signature in cervical lesions: identification of MACROD2 gene as HPV hot spot integration site. Arch Gynecol Obstet 307:1115–1123. doi: 10.1007/s00404-022-06748-1 PubMed DOI

Parfenov M, Pedamallu CS, Gehlenborg N, Freeman SS, Danilova L, Bristow CA, Lee S, Hadjipanayis AG, Ivanova EV, Wilkerson MD, et al. 2014. Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci USA 111:15544–15549. doi: 10.1073/pnas.1416074111 PubMed DOI PMC

Olthof NC, Speel E-J, Kolligs J, Haesevoets A, Henfling M, Ramaekers FCS, Preuss SF, Drebber U, Wieland U, Silling S, Lam WL, Vucic EA, Kremer B, Klussmann J-P, Huebbers CU. 2014. Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression. PLoS One 9:e88718. doi: 10.1371/journal.pone.0088718 PubMed DOI PMC

Tian R, Huang Z, Li L, Yuan J, Zhang Q, Meng L, Lang B, Hong Y, Zhong C, Tian X, Cui Z, Jin Z, Liu J, Huang Z, Wang Y, Chen Y, Hu Z. 2023. HPV integration generates a cellular super-enhancer which functions as ecDNA to regulate genome-wide transcription. Nucleic Acids Res 51:4237–4251. doi: 10.1093/nar/gkad105 PubMed DOI PMC

Hatano T, Sano D, Takahashi H, Hyakusoku H, Isono Y, Shimada S, Sawakuma K, Takada K, Oikawa R, Watanabe Y, Yamamoto H, Itoh F, Myers JN, Oridate N. 2017. Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines. Int J Cancer 140:1571–1580. doi: 10.1002/ijc.30589 PubMed DOI PMC

Badal V, Chuang LSH, Tan E-H, Badal S, Villa LL, Wheeler CM, Li BFL, Bernard H-U. 2003. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 77:6227–6234. doi: 10.1128/jvi.77.11.6227-6234.2003 PubMed DOI PMC

Rosendo-Chalma P, Antonio-Véjar V, Ortiz Tejedor JG, Ortiz Segarra J, Vega Crespo B, Bigoni-Ordóñez GD. 2024. The hallmarks of cervical cancer: molecular mechanisms induced by human papillomavirus. Biology (Basel) 13:77. doi: 10.3390/biology13020077 PubMed DOI PMC

Balaji H, Demers I, Wuerdemann N, Schrijnder J, Kremer B, Klussmann JP, Huebbers CU, Speel E-JM. 2021. Causes and consequences of HPV integration in head and neck squamous cell carcinomas: state of the art. Cancers (Basel) 13:4089. doi: 10.3390/cancers13164089 PubMed DOI PMC

Veitía D, Liuzzi J, Ávila M, Rodriguez I, Toro F, Correnti M. 2020. Association of viral load and physical status of HPV-16 with survival of patients with head and neck cancer. Ecancermedicalscience 14:1082. doi: 10.3332/ecancer.2020.1082 PubMed DOI PMC

Nambaru L, Meenakumari B, Swaminathan R, Rajkumar T. 2009. Prognostic significance of HPV physical status and integration sites in cervical cancer. Asian Pac J Cancer Prev 10:355–360. PubMed

Koneva LA, Zhang Y, Virani S, Hall PB, McHugh JB, Chepeha DB, Wolf GT, Carey TE, Rozek LS, Sartor MA. 2018. HPV integration in HNSCC correlates with survival outcomes, immune response signatures, and candidate drivers. Mol Cancer Res 16:90–102. doi: 10.1158/1541-7786.MCR-17-0153 PubMed DOI PMC

Nulton TJ, Kim N-K, DiNardo LJ, Morgan IM, Windle B. 2018. Patients with integrated HPV16 in head and neck cancer show poor survival. Oral Oncol 80:52–55. doi: 10.1016/j.oraloncology.2018.03.015 PubMed DOI PMC

Pinatti LM, Sinha HN, Brummel CV, Goudsmit CM, Geddes TJ, Wilson GD, Akervall JA, Brenner CJ, Walline HM, Carey TE. 2021. Association of human papillomavirus integration with better patient outcomes in oropharyngeal squamous cell carcinoma. Head Neck 43:544–557. doi: 10.1002/hed.26501 PubMed DOI PMC

Feng H, Shuda M, Chang Y, Moore PS. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096–1100. doi: 10.1126/science.1152586 PubMed DOI PMC

Wijaya WA, Liu Y, Qing Y, Li Z. 2022. Prevalence of Merkel cell polyomavirus in normal and lesional skin: a systematic review and meta-analysis. Front Oncol 12:868781. doi: 10.3389/fonc.2022.868781 PubMed DOI PMC

Sunshine JC, Jahchan NS, Sage J, Choi J. 2018. Are there multiple cells of origin of Merkel cell carcinoma? Oncogene 37:1409–1416. doi: 10.1038/s41388-017-0073-3 PubMed DOI PMC

Juan HY, Khachemoune A. 2023. A review of Merkel cell carcinoma. JAAPA 36:11–16. doi: 10.1097/01.JAA.0000979460.69305.b7 PubMed DOI

Jacobs D, Huang H, Olino K, Weiss S, Kluger H, Judson BL, Zhang Y. 2021. Assessment of age, period, and birth cohort effects and trends in Merkel cell carcinoma incidence in the United States. JAMA Dermatol 157:59. doi: 10.1001/jamadermatol.2020.4102 PubMed DOI PMC

Stang A, Becker JC, Nghiem P, Ferlay J. 2018. The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: an international assessment. Eur J Cancer 94:47–60. doi: 10.1016/j.ejca.2018.02.003 PubMed DOI PMC

Wieland U, Mauch C, Kreuter A, Krieg T, Pfister H. 2009. Merkel cell polyomavirus DNA in persons without Merkel cell carcinoma. Emerg Infect Dis 15:1496–1498. doi: 10.3201/eid1509.081575 PubMed DOI PMC

Foulongne V, Dereure O, Kluger N, Molès JP, Guillot B, Segondy M. 2010. Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases. Br J Dermatol 162:59–63. doi: 10.1111/j.1365-2133.2009.09381.x PubMed DOI

Schowalter RM, Pastrana DV, Pumphrey KA, Moyer AL, Buck CB. 2010. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 7:509–515. doi: 10.1016/j.chom.2010.05.006 PubMed DOI PMC

Bopp L, Wieland U, Hellmich M, Kreuter A, Pfister H, Silling S. 2021. Natural history of cutaneous human polyomavirus infection in healthy individuals. Front Microbiol 12:740947. doi: 10.3389/fmicb.2021.740947 PubMed DOI PMC

Saláková M, Košlabová E, Vojtěchová Z, Tachezy R, Šroller V. 2016. Detection of human polyomaviruses MCPyV, HPyV6, and HPyV7 in malignant and non-malignant tonsillar tissues. J Med Virol 88:695–702. doi: 10.1002/jmv.24385 PubMed DOI

Nicol JTJ, Robinot R, Carpentier A, Carandina G, Mazzoni E, Tognon M, Touzé A, Coursaget P. 2013. Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus. Clin Vaccine Immunol 20:363–368. doi: 10.1128/CVI.00438-12 PubMed DOI PMC

Zhang C, Liu F, He Z, Deng Q, Pan Y, Liu Y, Zhang C, Ning T, Guo C, Liang Y, Xu R, Zhang L, Cai H, Ke Y. 2014. Seroprevalence of Merkel cell polyomavirus in the general rural population of Anyang, China. PLoS One 9:e106430. doi: 10.1371/journal.pone.0106430 PubMed DOI PMC

Šroller V, Hamšíková E, Ludvíková V, Vochozková P, Kojzarová M, Fraiberk M, Saláková M, Morávková A, Forstová J, Němečková Š. 2014. Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general Czech Republic population. J Med Virol 86:1560–1568. doi: 10.1002/jmv.23841 PubMed DOI

Carter JJ, Daugherty MD, Qi X, Bheda-Malge A, Wipf GC, Robinson K, Roman A, Malik HS, Galloway DA. 2013. Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes. Proc Natl Acad Sci USA 110:12744–12749. doi: 10.1073/pnas.1303526110 PubMed DOI PMC

Seo GJ, Chen CJ, Sullivan CS. 2009. Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression. Virology (Auckl) 383:183–187. doi: 10.1016/j.virol.2008.11.001 PubMed DOI

Schowalter RM, Buck CB. 2013. The Merkel cell polyomavirus minor capsid protein. PLoS Pathog 9:e1003558. doi: 10.1371/journal.ppat.1003558 PubMed DOI PMC

Bayer NJ, Januliene D, Zocher G, Stehle T, Moeller A, Blaum BS. 2020. Structure of Merkel cell polyomavirus capsid and interaction with its glycosaminoglycan attachment receptor. J Virol 94:e01664-19. doi: 10.1128/JVI.01664-19 PubMed DOI PMC

Schowalter RM, Pastrana DV, Buck CB. 2011. Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog 7:e1002161. doi: 10.1371/journal.ppat.1002161 PubMed DOI PMC

Neu U, Hengel H, Blaum BS, Schowalter RM, Macejak D, Gilbert M, Wakarchuk WW, Imamura A, Ando H, Kiso M, Arnberg N, Garcea RL, Peters T, Buck CB, Stehle T. 2012. Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection. PLoS Pathog 8:e1002738. doi: 10.1371/journal.ppat.1002738 PubMed DOI PMC

Becker M, Dominguez M, Greune L, Soria-Martinez L, Pfleiderer MM, Schowalter R, Buck CB, Blaum BS, Schmidt MA, Schelhaas M. 2019. Infectious entry of Merkel cell polyomavirus. J Virol 93:e02004-18. doi: 10.1128/JVI.02004-18 PubMed DOI PMC

Liu W, Yang R, Payne AS, Schowalter RM, Spurgeon ME, Lambert PF, Xu X, Buck CB, You J. 2016. Identifying the target cells and mechanisms of Merkel cell polyomavirus infection. Cell Host Microbe 19:775–787. doi: 10.1016/j.chom.2016.04.024 PubMed DOI PMC

Liu W, Krump NA, MacDonald M, You J. 2018. Merkel cell polyomavirus infection of animal dermal fibroblasts. J Virol 92:e01610-17. doi: 10.1128/JVI.01610-17 PubMed DOI PMC

Liu W, Krump NA, Buck CB, You J. 2019. Merkel cell polyomavirus infection and detection. J Vis Exp. doi: 10.3791/58950 PubMed DOI PMC

Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y. 2008. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci USA 105:16272–16277. doi: 10.1073/pnas.0806526105 PubMed DOI PMC

Passerini S, Prezioso C, Babini G, Ferlosio A, Cosio T, Campione E, Moens U, Ciotti M, Pietropaolo V. 2023. Detection of Merkel Cell Polyomavirus (MCPyV) DNA and transcripts in Merkel Cell Carcinoma (MCC). Pathogens 12:894. doi: 10.3390/pathogens12070894 PubMed DOI PMC

Sihto H, Kukko H, Koljonen V, Sankila R, Böhling T, Joensuu H. 2011. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin Cancer Res 17:4806–4813. doi: 10.1158/1078-0432.CCR-10-3363 PubMed DOI

Verhaegen ME, Mangelberger D, Harms PW, Vozheiko TD, Weick JW, Wilbert DM, Saunders TL, Ermilov AN, Bichakjian CK, Johnson TM, Imperiale MJ, Dlugosz AA. 2015. Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice. J Invest Dermatol 135:1415–1424. doi: 10.1038/jid.2014.446 PubMed DOI PMC

Dye KN, Welcker M, Clurman BE, Roman A, Galloway DA. 2019. Merkel cell polyomavirus Tumor antigens expressed in Merkel cell carcinoma function independently of the ubiquitin ligases Fbw7 and β-TrCP. PLoS Pathog 15:e1007543. doi: 10.1371/journal.ppat.1007543 PubMed DOI PMC

Sergi MC, Lauricella E, Porta C, Tucci M, Cives M. 2023. An update on Merkel cell carcinoma. Biochim Biophys Acta Rev Cancer 1878:188880. doi: 10.1016/j.bbcan.2023.188880 PubMed DOI

Martel-Jantin C, Filippone C, Cassar O, Peter M, Tomasic G, Vielh P, Brière J, Petrella T, Aubriot-Lorton MH, Mortier L, Jouvion G, Sastre-Garau X, Robert C, Gessain A. 2012. Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma. Virology (Auckl) 426:134–142. doi: 10.1016/j.virol.2012.01.018 PubMed DOI

Starrett GJ, Thakuria M, Chen T, Marcelus C, Cheng J, Nomburg J, Thorner AR, Slevin MK, Powers W, Burns RT, Perry C, Piris A, Kuo FC, Rabinowits G, Giobbie-Hurder A, MacConaill LE, DeCaprio JA. 2020. Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma. Genome Med 12:30. doi: 10.1186/s13073-020-00727-4 PubMed DOI PMC

Czech-Sioli M, Günther T, Therre M, Spohn M, Indenbirken D, Theiss J, Riethdorf S, Qi M, Alawi M, Wülbeck C, Fernandez-Cuesta I, Esmek F, Becker JC, Grundhoff A, Fischer N. 2020. High-resolution analysis of Merkel cell polyomavirus in Merkel cell carcinoma reveals distinct integration patterns and suggests NHEJ and MMBIR as underlying mechanisms. PLoS Pathog 16:e1008562. doi: 10.1371/journal.ppat.1008562 PubMed DOI PMC

Starrett GJ, Marcelus C, Cantalupo PG, Katz JP, Cheng J, Akagi K, Thakuria M, Rabinowits G, Wang LC, Symer DE, Pipas JM, Harris RS, DeCaprio JA. 2017. Merkel cell polyomavirus exhibits dominant control of the tumor genome and transcriptome in virus-associated merkel cell carcinoma. mBio 8:e02079-16. doi: 10.1128/mBio.02079-16 PubMed DOI PMC

Laude HC, Jonchère B, Maubec E, Carlotti A, Marinho E, Couturaud B, Peter M, Sastre-Garau X, Avril M-F, Dupin N, Rozenberg F. 2010. Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma. PLoS Pathog 6:e1001076. doi: 10.1371/journal.ppat.1001076 PubMed DOI PMC

Nirenberg A, Steinman H, Dixon J, Dixon A. 2020. Merkel cell carcinoma update: the case for two tumours. J Eur Acad Dermatol Venereol 34:1425–1431. doi: 10.1111/jdv.16158 PubMed DOI

Sundqvist BZ, Kilpinen SK, Böhling TO, Koljonen VSK, Sihto HJ. 2023. Transcriptomic analyses reveal three distinct molecular subgroups of Merkel cell carcinoma with differing prognoses. Int J Cancer 152:2099–2108. doi: 10.1002/ijc.34425 PubMed DOI

Bill CA, Summers J. 2004. Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration. Proc Natl Acad Sci USA 101:11135–11140. doi: 10.1073/pnas.0403925101 PubMed DOI PMC

Yang L, Ye S, Zhao X, Ji L, Zhang Y, Zhou P, Sun J, Guan Y, Han Y, Ni C, Hu X, Liu W, Wang H, Zhou B, Huang J. 2018. Molecular characterization of HBV DNA integration in patients with hepatitis and hepatocellular carcinoma. J Cancer 9:3225–3235. doi: 10.7150/jca.26052 PubMed DOI PMC

Li X, Zhang J, Yang Z, Kang J, Jiang S, Zhang T, Chen T, Li M, Lv Q, Chen X, McCrae MA, Zhuang H, Lu F. 2014. The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma. J Hepatol 60:975–984. doi: 10.1016/j.jhep.2013.12.014 PubMed DOI

Tian R, Wang Y, Li W, Cui Z, Pan T, Jin Z, Huang Z, Li L, Lang B, Wu J, Xie H, Lu Y, Tian X, Hu Z. 2022. Genome-wide virus-integration analysis reveals a common insertional mechanism of HPV, HBV and EBV. Clin Transl Med 12:e971. doi: 10.1002/ctm2.971 PubMed DOI PMC

Groves IJ, Coleman N. 2018. Human papillomavirus genome integration in squamous carcinogenesis: what have next-generation sequencing studies taught us? J Pathol 245:9–18. doi: 10.1002/path.5058 PubMed DOI

Porter VL, Marra MA. 2022. The drivers, mechanisms, and consequences of genome instability in HPV-driven cancers. Cancers (Basel) 14:4623. doi: 10.3390/cancers14194623 PubMed DOI PMC

Akagi K, Symer DE, Mahmoud M, Jiang B, Goodwin S, Wangsa D, Li Z, Xiao W, Dunn JD, Ried T, Coombes KR, Sedlazeck FJ, Gillison ML. 2023. Intratumoral heterogeneity and clonal evolution induced by HPV integration. Cancer Discov 13:910–927. doi: 10.1158/2159-8290.CD-22-0900 PubMed DOI PMC

Ceccaldi R, Liu JC, Amunugama R, Hajdu I, Primack B, Petalcorin MIR, O’Connor KW, Konstantinopoulos PA, Elledge SJ, Boulton SJ, Yusufzai T, D’Andrea AD. 2015. Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair. Nature 518:258–262. doi: 10.1038/nature14184 PubMed DOI PMC

Leeman JE, Li Y, Bell A, Hussain SS, Majumdar R, Rong-Mullins X, Blecua P, Damerla R, Narang H, Ravindran PT, Lee NY, Riaz N, Powell SN, Higginson DS. 2019. Human papillomavirus 16 promotes microhomology-mediated end-joining. Proc Natl Acad Sci USA 116:21573–21579. doi: 10.1073/pnas.1906120116 PubMed DOI PMC

Chakraborty PR, Ruiz-Opazo N, Shouval D, Shafritz DA. 1980. Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line. Nature 286:531–533. doi: 10.1038/286531a0 PubMed DOI

Lace MJ, Anson JR, Klussmann JP, Wang DH, Smith EM, Haugen TH, Turek LP. 2011. Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers. J Virol 85:1645–1654. doi: 10.1128/JVI.02093-10 PubMed DOI PMC

Gardella T, Medveczky P, Sairenji T, Mulder C. 1984. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J Virol 50:248–254. doi: 10.1128/jvi.50.1.248-254.1984 PubMed DOI PMC

Chang Y, Cheng S-D, Tsai C-H. 2002. Chromosomal integration of Epstein - Barr virus genomes in nasopharyngeal carcinoma cells. Head Neck 24:143–150. doi: 10.1002/hed.10039 PubMed DOI

Whitehouse A. 2011. Gardella gel analysis to detect Herpesvirus saimiri episomal DNA. Cold Spring Harb Protoc 2011:1524–1526. doi: 10.1101/pdb.prot066969 PubMed DOI

Begum S, Cao D, Gillison M, Zahurak M, Westra WH. 2005. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 11:5694–5699. doi: 10.1158/1078-0432.CCR-05-0587 PubMed DOI

Brooks EG, Evans MF, Adamson C-C, Peng Z, Rajendran V, Laucirica R, Cooper K. 2012. In situ hybridization signal patterns in recurrent laryngeal squamous papillomas indicate that HPV integration occurs at an early stage. Head Neck Pathol 6:32–37. doi: 10.1007/s12105-011-0308-5 PubMed DOI PMC

Xiong J, Cheng J, Shen H, Ren C, Wang L, Gao C, Zhu T, Li X, Ding W, Zhu D, Wang H. 2021. Detection of HPV and human chromosome sites by dual-color fluorescence in situ hybridization reveals recurrent HPV integration sites and heterogeneity in cervical cancer. Front Oncol 11:734758. doi: 10.3389/fonc.2021.734758 PubMed DOI PMC

Tokino T, Matsubara K. 1991. Chromosomal sites for hepatitis B virus integration in human hepatocellular carcinoma. J Virol 65:6761–6764. doi: 10.1128/JVI.65.12.6761-6764.1991 PubMed DOI PMC

Redmond CJ, Fu H, Aladjem MI, McBride AA. 2018. Human papillomavirus integration: analysis by molecular combing and fiber-FISH. Curr Protoc Microbiol 51:e61. doi: 10.1002/cpmc.61 PubMed DOI PMC

Takada S, Gotoh Y, Hayashi S, Yoshida M, Koike K. 1990. Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues. J Virol 64:822–828. doi: 10.1128/JVI.64.2.822-828.1990 PubMed DOI PMC

Minami M, Poussin K, Bréchot C, Paterlini P. 1995. A novel PCR technique UsingAlu-specific primers to identify unknown flanking sequences from the human genome. Genomics 29:403–408. doi: 10.1006/geno.1995.9004 PubMed DOI

Tu T, Jilbert AR. 2017. Detection of hepatocyte clones containing integrated hepatitis B virus DNA using inverse nested PCR. Methods Mol Biol 1540:97–118. doi: 10.1007/978-1-4939-6700-1_9 PubMed DOI

Luft F, Klaes R, Nees M, Dürst M, Heilmann V, Melsheimer P, von Knebel Doeberitz M. 2001. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 92:9–17. doi: 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L PubMed DOI

Matovina M, Sabol I, Grubišić G, Gašperov NM, Grce M. 2009. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol Oncol 113:120–127. doi: 10.1016/j.ygyno.2008.12.004 PubMed DOI

Schrama D, Sarosi E-M, Adam C, Ritter C, Kaemmerer U, Klopocki E, König E-M, Utikal J, Becker JC, Houben R. 2019. Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: integration pattern suggest that large T antigen truncating events occur before or during integration. Int J Cancer 145:1020–1032. doi: 10.1002/ijc.32280 PubMed DOI

Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, Lotz B, Melsheimer P, von Knebel Doeberitz M. 1999. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59:6132–6136. PubMed

Ziegert C, Wentzensen N, Vinokurova S, Kisseljov F, Einenkel J, Hoeckel M, von Knebel Doeberitz M. 2003. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene 22:3977–3984. doi: 10.1038/sj.onc.1206629 PubMed DOI

Kim S-H, Koo B-S, Kang S, Park K, Kim H, Lee KR, Lee MJ, Kim JM, Choi EC, Cho NH. 2007. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer 120:1418–1425. doi: 10.1002/ijc.22464 PubMed DOI

Cricca M, Morselli-Labate AM, Venturoli S, Ambretti S, Gentilomi GA, Gallinella G, Costa S, Musiani M, Zerbini M. 2007. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Gynecol Oncol 106:549–557. doi: 10.1016/j.ygyno.2007.05.004 PubMed DOI

Deng Z, Hasegawa M, Kiyuna A, Matayoshi S, Uehara T, Agena S, Yamashita Y, Ogawa K, Maeda H, Suzuki M. 2013. Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma. Head Neck 35:800–808. doi: 10.1002/hed.23034 PubMed DOI

Wang Q, Jia P, Zhao Z. 2013. VirusFinder: software for efficient and accurate detection of viruses and their integration sites in host genomes through next generation sequencing data. PLoS One 8:e64465. doi: 10.1371/journal.pone.0064465 PubMed DOI PMC

Fujimoto A, Furuta M, Totoki Y, Tsunoda T, Kato M, Shiraishi Y, Tanaka H, Taniguchi H, Kawakami Y, Ueno M, et al. 2016. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. Nat Genet 48:500–509. doi: 10.1038/ng.3547 PubMed DOI

Wang A, Wu L, Lin J, Han L, Bian J, Wu Y, Robson SC, Xue L, Ge Y, Sang X, Wang W, Zhao H. 2018. Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma. Nat Commun 9:894. doi: 10.1038/s41467-018-03276-y PubMed DOI PMC

Svicher V, Salpini R, Piermatteo L, Carioti L, Battisti A, Colagrossi L, Scutari R, Surdo M, Cacciafesta V, Nuccitelli A, Hansi N, Ceccherini Silberstein F, Perno CF, Gill US, Kennedy PTF. 2021. Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B. Gut 70:2337–2348. doi: 10.1136/gutjnl-2020-323300 PubMed DOI PMC

Tuna M, Amos CI. 2017. Next generation sequencing and its applications in HPV-associated cancers. Oncotarget 8:8877–8889. doi: 10.18632/oncotarget.12830 PubMed DOI PMC

Fukano K, Wakae K, Nao N, Saito M, Tsubota A, Toyoshima T, Aizaki H, Iijima H, Matsudaira T, Kimura M, Watashi K, Sugiura W, Muramatsu M. 2023. A versatile method to profile hepatitis B virus DNA integration. Hepatol Commun 7:e0328. doi: 10.1097/HC9.0000000000000328 PubMed DOI PMC

Yang W, Liu Y, Dong R, Liu J, Lang J, Yang J, Wang W, Li J, Meng B, Tian G. 2020. Accurate detection of HPV integration sites in cervical cancer samples using the nanopore MinION sequencer without error correction. Front Genet 11:660. doi: 10.3389/fgene.2020.00660 PubMed DOI PMC

Andersen K, Holm K, Tranberg M, Pedersen CL, Bønløkke S, Steiniche T, Andersen B, Stougaard M. 2022. Targeted next generation sequencing for human papillomavirus genotyping in cervical liquid-based cytology samples. Cancers (Basel) 14:652. doi: 10.3390/cancers14030652 PubMed DOI PMC

Liang J, Cui Z, Wu C, Yu Y, Tian R, Xie H, Jin Z, Fan W, Xie W, Huang Z, Xu W, Zhu J, You Z, Guo X, Qiu X, Ye J, Lang B, Li M, Tan S, Hu Z. 2021. DeepEBV: a deep learning model to predict Epstein-Barr virus (EBV) integration sites. Bioinformatics 37:3405–3411. doi: 10.1093/bioinformatics/btab388 PubMed DOI

Valmary-Degano S, Jacquin E, Prétet J-L, Monnien F, Girardo B, Arbez-Gindre F, Joly M, Bosset J-F, Kantelip B, Mougin C. 2013. Signature patterns of human papillomavirus type 16 in invasive anal carcinoma. Hum Pathol 44:992–1002. doi: 10.1016/j.humpath.2012.08.019 PubMed DOI

Lang B, Dong D, Zhao T, Zhong R, Qin H, Cao C, Wang Y, Liu T, Liang W, Tian X, Yan Y, Hu Z. 2023. A cross-sectional study of human papillomavirus genotype distribution and integration status in penile cancer among Chinese population. Virology (Auckl) 584:53–57. doi: 10.1016/j.virol.2023.04.013 PubMed DOI

Rodig SJ, Cheng J, Wardzala J, DoRosario A, Scanlon JJ, Laga AC, Martinez-Fernandez A, Barletta JA, Bellizzi AM, Sadasivam S, Holloway DT, Cooper DJ, Kupper TS, Wang LC, DeCaprio JA. 2012. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest 122:4645–4653. doi: 10.1172/JCI64116 PubMed DOI PMC

Lim MY, Dahlstrom KR, Sturgis EM, Li G. 2016. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma. Head Neck 38:1139–1144. doi: 10.1002/hed.24429 PubMed DOI